Key points are not available for this paper at this time.
Abstract The effect of the cross‐coupling catalyst tetrakis (triphenylphosphine) palladium (0) (Pd (PPh 3) 4) on the performance of a model organic bulk‐heterojunction solar cell composed of a blend of poly (2, 6′‐4, 8‐di (5‐ethylhexylthienyl) benzo[1, 2‐b;3, 3‐bdithiophene]3‐fluoro‐2 (2‐ethylhexyl) carbonylthieno3, 4‐bthiophenediyl) (PTB7‐Th) donor and 3, 9‐bis (2‐methylene‐ ( (3‐ (1, 1‐dicyanomethylene) ‐6, 7‐difluoro) ‐indanone) ) ‐5, 5, 11, 11‐tetrakis (4‐hexylphenyl) ‐dithieno2, 3‐d: 2′, 3′‐d′‐s‐indaceno1, 2‐b: 5, 6‐b′dithiophene (IOTIC‐4F) non‐fullerene acceptor is investigated. The effect of intentional addition of different amounts of Pd (PPh 3) 4 on morphology, free charge carrier generation, non‐geminate bulk trap‐ and surface trap‐assisted recombination as well as bimolecular recombination and charge extraction is quantified. This work shows that free charge carrier generation is affected significantly, while the impact of Pd (PPh 3) 4 on non‐geminate recombination processes is limited because the catalyst does not facilitate efficient trap‐assisted recombination. The studied system shows substantial robustness towards the addition of Pd (PPh 3) 4 in small amounts.
Schopp et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: